Authors/Disclosures
|
Carmen Bozic, MD
(Biogen Idec)
|
No disclosure on file |
|
|
No disclosure on file |
|
Mariska Kooijmans-Coutinho, MD, PhD
(Biogen Idec. Ltd)
|
No disclosure on file |
|
Richard K. Kim, MD
|
Dr. Kim has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for RKK Consulting, Inc.. |
|
Robert Hyde, PhD
(Biogen)
|
Dr. Hyde has received personal compensation for serving as an employee of Biogen International GmbH . Dr. Hyde has received stock or an ownership interest from Biogen . |
|
Frances Lynn, MSC
|
No disclosure on file |
|
Michael A. Panzara, MD, MPH
(Neurvati Neurosciences)
|
Dr. Panzara has received personal compensation for serving as an employee of Neurvati Neurosciences. Dr. Panzara has received personal compensation for serving as an employee of GRIN Therapeutics. Dr. Panzara has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Wave Life Sciences. Dr. Panzara has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Athira Pharma. Dr. Panzara has stock in GRIN Therapeutics. Dr. Panzara has stock in Cadenza Bio. Dr. Panzara has stock in Athira Pharma. Dr. Panzara has stock in Wave Life Sciences. Dr. Panzara has stock in Sanofi. |
|
Juliana Almeida, MD
(HC FMUSP)
|
No disclosure on file |